본문 바로가기
KERD
논문KCI 등재

건강보험 청구자료에서 동반질환 보정방법과 관찰기간 비교 연구 : 경피적 관상동맥 중재술을 받은 환자를 대상으로

A Comparative Study on Comorbidity Measurements with Lookback Period using Health Insurance Database: Focused on Patients Who Underwent Percutaneous Coronary Intervention

2

조회

0

다운로드

10

인용

0

참고문헌

키워드

초록

Objectives : To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser s comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for patients who underwent percutaneous coronary intervention. Methods : This was a retrospective study on patients aged 40 years and older who underwent percutaneous coronary intervention. To distinguish comorbidity from complications, the records of diagnosis were drawn from the National Health Insurance Database excluding diagnosis that admitted to the hospital. C-statistic values were used as measures for in comparing the predictability of comorbidity measures with lookback period, and a bootstrapping procedure with 1,000 replications was done to determine approximate 95% confidence interval. Results : Of the 61,815 patients included in this study, the mean age was 63.3 years (standard deviation: ± 10.2) and 64.8% of the population was male. Among them, 1,598 (2.6%) had died in hospital. While the predictive ability of the Elixhauser s comorbidity and comorbidity selection was better than that of the Charlson comorbidity index, there was no significant difference among the three comorbidity measurements. Although the prevalence of comorbidity increased in 3 years of lookback periods, there was no significant improvement compared to 1 year of a lookback period. Conclusions : In a health outcome study for patients who underwent percutaneous coronary intervention using National Health Insurance Database, the Charlson comorbidity index was easy to apply without significant difference in predictability compared to the other methods. The one year of observation period was adequate to adjust the comorbidity. Further work to select adequate comorbidity measurements and lookback periods on other diseases and procedures are needed.

Abstract

Objectives : To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser s comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for patients who underwent percutaneous coronary intervention. Methods : This was a retrospective study on patients aged 40 years and older who underwent percutaneous coronary intervention. To distinguish comorbidity from complications, the records of diagnosis were drawn from the National Health Insurance Database excluding diagnosis that admitted to the hospital. C-statistic values were used as measures for in comparing the predictability of comorbidity measures with lookback period, and a bootstrapping procedure with 1,000 replications was done to determine approximate 95% confidence interval. Results : Of the 61,815 patients included in this study, the mean age was 63.3 years (standard deviation: ± 10.2) and 64.8% of the population was male. Among them, 1,598 (2.6%) had died in hospital. While the predictive ability of the Elixhauser s comorbidity and comorbidity selection was better than that of the Charlson comorbidity index, there was no significant difference among the three comorbidity measurements. Although the prevalence of comorbidity increased in 3 years of lookback periods, there was no significant improvement compared to 1 year of a lookback period. Conclusions : In a health outcome study for patients who underwent percutaneous coronary intervention using National Health Insurance Database, the Charlson comorbidity index was easy to apply without significant difference in predictability compared to the other methods. The one year of observation period was adequate to adjust the comorbidity. Further work to select adequate comorbidity measurements and lookback periods on other diseases and procedures are needed.

참고문헌 (27)

  1. Cleves MA, "Evaluation of two competing methods for calculating Charlson s comorbidity index when analyzing short-term mortality using administrative data", J Clin Epidemiol, 50(8), pp.903~908 (1997)
  2. Kim HY, (2007), Korea University
  3. 이광수, "관상동맥우회로술 환자의 위험도에 따른 수술량과 병원내 사망의 관련성", 예방의학회지, 39(1), pp.13~20 (2006), 대한예방의학회
  4. Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation", J Chronic Dis, 40(5), pp.373~383 (1987)
  5. Schneeweiss S, "Improved comorbidity adjustment for predicting mortality in medicare populations", Health Serv Res, 38(4), pp.1103~1120 (2003)
  6. Birim O, "Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer", Eur J Cardiothorac Surg, 28(5), pp.759~762 (2005)
  7. Birim O, "Validation of the Charlson comorbidity index in patients with operated primary non-small celllung cancer", Eur J Cardiothorac Surg, 23(1), pp.30~34 (2003)
  8. Elixhauser A, "Comorbidity measures for use with administrative data", Med Care, 36(1), pp.8~27 (1998)
  9. Stukenborg GJ, "Comparison of the performance of two comorbidity measures, with and without information from prior hospitalization", Med Care, 39(7), pp.727~739 (2001)
  10. Southern DA, "Comparison of the Elixhauser and Charlson", Deyo methods of comorbidity measurement in administrative data, 2004, pp.42(4), 355~360
  11. Preen DB, "Length of comorbidity lookback period affected regression model performance of administrative health data", J Clin Epidemiol, 59(9), pp.940~946 (2006)
  12. Lee DS, "Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research", Med Care, 43(2), pp.182~188 (2005)
  13. AHRQ Quality Indicators-Guide to Inpatient Quality Indicators: Quality of Care in Hospitals-Volume, Mortality, and Utilization, "Agency for Healthcare Research and Quality", ~, pp.02-RO204. (2002)
  14. Alidoosti M, "Comparison of outcomes of percutaneous coronary intervetion on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: A corss-sectional study", BMC Cardiovacs Disord, 7, pp.7~ (2007)
  15. Burton KR, "Hosptial volume of throughput and periprocedural and mediumterm adverse events after percutaneous coronary intervention: Retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003", Heart, 92(11), pp.1667~1672 (2006)
  16. Carey JS, "Procedure rates and outcomes of coronary revascularization procedures in California and New York", J Thorac Cardiovasc Surg, 129(6), pp.1276~1282 (2005)
  17. Epstein AJ, "Volume-based referral for cardiovascular procedures in the United States: A crosssectional regression analysis", BMC Health Serv Res, 5, pp.42~ (2005)
  18. Harjai KJ, "Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting", Am J Cardiol, 94(4), pp.421~426 (2004)
  19. Halfon P, "Measuring potentially avoidable hospital readmissions", J Clin Epidemiol, 55(6), pp.573~587 (2002)
  20. Sundararajan V, "New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality", J Clin Epidemiol, 57(12), pp.1288~1294 (2004)
  21. Sundararajan V, "Cross-national comparative performance of three versions of the ICD-10 Charlson index", Med Care, 45(12), pp.1210~1215 (2007)
  22. Quan H, "Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data", Med Care, 43(11), pp.1130~1139 (2005)
  23. Klabunde CN, "Development of a comorbidity index using physician claims data", J Clin Epidemiol, 53(12), pp.1258~1267 (2000)
  24. Li B, "Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases", BMC Health Serv Res, 8, pp.12~ (2008)
  25. Zavascki AP, "The need for reappraisal of AIDS score weight of Charlson comorbidity index", J Clin Epidemiol, 60(9), pp.867~868 (2007)
  26. Zhang JX, "The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in medicare claims", Med Care, 37(11), pp.1128~1139 (1999)
  27. Kim JY, "Development of Risk Adjustment and Prediction Methods for Care Episodes using National Health Insurance Database" (2007), Health Insurance Review & Assessment Service

관련 논문AI추천

이 간행물의 다른 논문 (8건)